Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
AssigneeUniversity of Pittsburgh
InventorsAnthony J. Bauer, Gisela Bruenagel, Robert H. Getzenberg, Robert E. Schoen
Life of this patent
Estimating the term…
Abstract
Proteins useful in the diagnosis of proliferative disorders of the colon are present in nuclear matrix protein preparations and can be characterized by molecular weight, isoelectric point, and amino acid sequence. The proteins may be identified, for example, by 2D-gel electrophoresis or by specific binding partners, such as antibodies.
Claims78
A purified protein which is present in cancerous colon cells but absent or reduced in amount in normal colonic epithelial cells, said protein selected from the group consisting of:
- a) CC2 having a molecular weight of about 56 kD and a pI of about 6.22;
- b) CC3 having a molecular weight of about 43 kD and a pI of about 6.3;
- c) CC4 having a molecular weight of about 43 kD and a pI of about 6.2;
- d) CC5 having a molecular weight of about 42 kD and a pI of about 6.2;
- e) CC6a having a molecular weight of about 20 kD and a pI of about 6.9;
- f) CC6b having a molecular weight of about 20 kD and a pI of about 6.8.
- g) L1 having a molecular weight of about 50 kD and a pI of about 6.01;
- h) L2 having a molecular weight of about 20 kD and a pI of about 5.73;
- and
- i) L5 having a molecular weight of about 19 kD and a pI of about 5.88.
A purified protein which is present in normal epithelial colonic cells but absent or reduced in amount cancerous colon cells, said protein selected from the group consisting of:
- a) N1 having a molecular weight of about 40 kD and a pI of about 5.5;
- b) N2 having a molecular weight of about 30 kD and a pI of about 5.94;
- c) N3 having a molecular weight of about 30 kD and a pI of about 5.88;
- d) N4 having a molecular weight of about 30 kD and a pI of about 5.80;
- e) N5 having a molecular weight of about 30 kD and a pI of about 5.73;
- and
- f) N6 having a molecular weight of about 18 kD and a pI of about 6.6.
A purified protein which is present in primary colon cancer cells and liver metastasis derived therefrom and is useful as a cancer diagnostic marker, said protein selected from the group consisting of:
- a) L3 having a molecular weight of about 18 kD and a pI of about 6.09;
- and
- b) L4 having a molecular weight of about 18 kD and a pI of about 6.00.
A method of diagnosing a proliferative disorder of the colon in a patient, said method comprising:
- analyzing tissue, stool or body fluid from the patient for the presence of at least one protein that is present in cancerous colonic cells but absent or reduced in amount in normal colonic epithelial cells, or present in normal colonic epithelial cells but absent or reduced in amount in cancerous colonic cells, wherein said protein is selected from the group consisting of:
- a) CC2 having a molecular weight of about 56 kD and a pI of about 6.22;
- b) CC3 having a molecular weight of about 43 kD and a pI of about 6.3;
- c) CC4 having a molecular weight of about 43 kD and a pI of about 6.2;
- d) CC5 having a molecular weight of about 42 kD and a pI of about 6.2;
- e) CC6a having a molecular weight of about 20 kD and a pI of about 6.9;
- f) CC6b having a molecular weight of about 20 kD and a pI of about 6.8.
- g) L1 having a molecular weight of about 50 kD and a pI of about 6.01;
- h) L2 having a molecular weight of about 20 kD and a pI of about 5.73;
- i) L5 having a molecular weight of about 19 kD and a pI of about 5.88;
- j) N1 having a molecular weight of about 40 kD and a pI of about 5.5;
- k) N2 having a molecular weight of about 30 kD and a pI of about 5.94;
- l) N3 having a molecular weight of about 30 kD and a pI of about 5.88;
- m) N4 having a molecular weight of about 30 kD and a pI of about 5.80;
- n) N5 having a molecular weight of about 30 kD and a pI of about 5.73;
- and
- o) N6 having a molecular weight of about 18 kD and a pI of about 6.6.
A method of diagnosing colon cancer in a patient, said method comprising:
- analyzing tissue, stool or body fluid from the patient for the presence of calreticulin.
A method of evaluating colonic adenomas for potential to become malignant, said method comprising:
- analyzing the adenoma for the presence of at least one protein that is present in cancerous colonic cells but absent or reduced in amount in normal colonic epithelial cells, or present in normal colonic epithelial cells but absent or reduced in amount in cancerous colonic cells, wherein said protein is selected from the group consisting of:
- a) CC2 having a molecular weight of about 56 kD and a pI of about 6.22;
- b) CC3 having a molecular weight of about 43 kD and a pI of about 6.3;
- c) CC4 having a molecular weight of about 43 kD and a pI of about 6.2;
- d) CC5 having a molecular weight of about 42 kD and a pI of about 6.2;
- e) CC6a having a molecular weight of about 20 kD and a pI of about 6.9;
- f) CC6b having a molecular weight of about 20 kD and a pI of about 6.8.
- g) L1 having a molecular weight of about 50 kD and a pI of about 6.01;
- h) L2 having a molecular weight of about 20 kD and a pI of about 5.73;
- i) L5 having a molecular weight of about 19 kD and a pI of about 5.88;
- j) N1 having a molecular weight of about 40 kD and a pI of about 5.5;
- k) N2 having a molecular weight of about 30 kD and a pI of about 5.94;
- l) N3 having a molecular weight of about, 30 kD and a pI of about 5.88;
- m) N4 having a molecular weight of about 30 kD and a pI of about 5.80;
- n) N5 having a molecular weight of about 30 kD and a pI of about 5.73;
- and
- o) N6 having a molecular weight of about 18 kD and a pI of about 6.6;
- and
- wherein detection of said proteins indicates an increased potential to become malignant.
A method of diagnosing colon cancer to liver metastasis in a patient, said method comprising:
- analyzing a sample of liver for the presence of at least one protein, wherein said protein is selected from the group consisting of:
- a) L1 having a molecular weight of about 50 kD and a pI of about 6.01;
- b) L2 having a molecular weight of about 20 kD and a pI of about 5.73;
- c) L3 having a molecular weight of about 17 kD and a pI of about 6.09;
- d) L4 having a molecular weight of about 17 kD and a pI of about 6.00;
- and
- e) L5 having a molecular weight of about 19 kD and a pI of about 5.88.
Dependencies are inferred from the claim text.